1. Home
  2. CALC vs AWRE Comparison

CALC vs AWRE Comparison

Compare CALC & AWRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • AWRE
  • Stock Information
  • Founded
  • CALC 2011
  • AWRE 1986
  • Country
  • CALC United States
  • AWRE United States
  • Employees
  • CALC N/A
  • AWRE N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • AWRE Computer Software: Prepackaged Software
  • Sector
  • CALC Health Care
  • AWRE Technology
  • Exchange
  • CALC Nasdaq
  • AWRE Nasdaq
  • Market Cap
  • CALC 22.9M
  • AWRE 34.6M
  • IPO Year
  • CALC N/A
  • AWRE 1996
  • Fundamental
  • Price
  • CALC $1.61
  • AWRE $1.83
  • Analyst Decision
  • CALC Strong Buy
  • AWRE
  • Analyst Count
  • CALC 3
  • AWRE 0
  • Target Price
  • CALC $16.33
  • AWRE N/A
  • AVG Volume (30 Days)
  • CALC 29.5K
  • AWRE 51.3K
  • Earning Date
  • CALC 08-11-2025
  • AWRE 08-07-2025
  • Dividend Yield
  • CALC N/A
  • AWRE N/A
  • EPS Growth
  • CALC N/A
  • AWRE N/A
  • EPS
  • CALC N/A
  • AWRE N/A
  • Revenue
  • CALC N/A
  • AWRE $16,576,000.00
  • Revenue This Year
  • CALC N/A
  • AWRE N/A
  • Revenue Next Year
  • CALC N/A
  • AWRE N/A
  • P/E Ratio
  • CALC N/A
  • AWRE N/A
  • Revenue Growth
  • CALC N/A
  • AWRE N/A
  • 52 Week Low
  • CALC $1.42
  • AWRE $1.35
  • 52 Week High
  • CALC $5.97
  • AWRE $2.97
  • Technical
  • Relative Strength Index (RSI)
  • CALC 47.03
  • AWRE 55.37
  • Support Level
  • CALC $1.42
  • AWRE $1.78
  • Resistance Level
  • CALC $1.85
  • AWRE $1.93
  • Average True Range (ATR)
  • CALC 0.16
  • AWRE 0.15
  • MACD
  • CALC 0.00
  • AWRE -0.01
  • Stochastic Oscillator
  • CALC 44.19
  • AWRE 22.95

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

Share on Social Networks: